Yokus Beran, Cakir Dilek Ulker, Akdag M Zulkuf, Sert Cemil, Mete Nuriye
Department of Biochemistry, Faculty of Veterinary, Dicle University, 21280 Diyarbakir, Turkey.
Free Radic Res. 2005 Mar;39(3):317-23. doi: 10.1080/10715760500043603.
Extremely low frequency (ELF) electromagnetic field (EMF) is thought to prolong the life of free radicals and can act as a promoter or co-promoter of cancer. 8-hydroxy-2'-deoxyguanosine (8OHdG) is one of the predominant forms of radical-induced lesions to DNA and is a potential tool to asses the cancer risk. We examined the effects of extremely low frequency electro magnetic field (ELF-EMF) (50 Hz, 0.97 mT) on 8OHdG levels in DNA and thiobarbituric acid reactive substances (TBARS) in plasma. To examine the possible time-dependent changes resulting from magnetic field, 8OHdG and TBARS were quantitated at 50 and 100 days. Our results showed that the exposure to ELF-EMF induced oxidative DNA damage and lipid peroxidation (LPO). The 8OHdG levels of exposed group (4.39+/-0.88 and 5.29+/-1.16 8OHdG/dG.10(5), respectively) were significantly higher than sham group at 50 and 100 days (3.02+/-0.63 and 3.46+/-0.38 8OHdG/dG.10(5)) (p<0.001, p<0.001). The higher TBARS levels were also detected in the exposure group both on 50 and 100 days (p<0.001, p<0.001). In addition, the extent of DNA damage and LPO would depend on the exposure time (p<0.05 and p<0.05). Our data may have important implications for the long-term exposure to ELF-EMF which may cause oxidative DNA damage.
极低频(ELF)电磁场(EMF)被认为会延长自由基的寿命,并可作为癌症的促进剂或共促进剂。8-羟基-2'-脱氧鸟苷(8OHdG)是自由基诱导的DNA损伤的主要形式之一,是评估癌症风险的潜在工具。我们研究了极低频电磁场(ELF-EMF)(50Hz,0.97mT)对DNA中8OHdG水平和血浆中硫代巴比妥酸反应性物质(TBARS)的影响。为了研究磁场可能导致的时间依赖性变化,在第50天和第100天对8OHdG和TBARS进行了定量。我们的结果表明,暴露于ELF-EMF会诱导氧化性DNA损伤和脂质过氧化(LPO)。在第50天和第100天,暴露组的8OHdG水平(分别为4.39±0.88和5.29±1.16 8OHdG/dG·10⁵)显著高于假手术组(3.02±0.63和3.46±0.38 8OHdG/dG·10⁵)(p<0.001,p<0.001)。在第50天和第100天,暴露组的TBARS水平也较高(p<0.001,p<0.001)。此外,DNA损伤和LPO的程度取决于暴露时间(p<0.05和p<0.05)。我们的数据可能对长期暴露于ELF-EMF会导致氧化性DNA损伤具有重要意义。
Free Radic Res. 2005-3
J Physiol Pharmacol. 2010-6
Int J Radiat Biol. 2008-10
J Physiol Pharmacol. 2011-12
Curr Neuropharmacol. 2022-3-4
Oxid Med Cell Longev. 2018-12-13
Sci Rep. 2018-10-19